Dr. Richard Soucier, MD
NPI: 1255334207
Total Payments
$278,374
2024 Payments
$514.35
Companies
18
Transactions
331
Medicare Patients
1,142
Medicare Billing
$127,494
Payment Breakdown by Category
Other$236,174 (84.8%)
Consulting$18,748 (6.7%)
Travel$13,743 (4.9%)
Food & Beverage$9,680 (3.5%)
Education$29.75 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $236,174 | 79 | 84.8% |
| Consulting Fee | $18,748 | 18 | 6.7% |
| Travel and Lodging | $13,743 | 71 | 4.9% |
| Food and Beverage | $9,680 | 161 | 3.5% |
| Education | $29.75 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $205,196 | 189 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $41,883 | 48 | $0 (2021) |
| Abbott Laboratories | $19,229 | 49 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $7,876 | 13 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,760 | 1 | $0 (2021) |
| Medtronic, Inc. | $1,060 | 1 | $0 (2020) |
| Lilly USA, LLC | $750.00 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $146.43 | 6 | $0 (2024) |
| PFIZER INC. | $122.31 | 6 | $0 (2024) |
| Corcept Therapeutics | $64.41 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $514.35 | 24 | PFIZER INC. ($81.27) |
| 2023 | $189.58 | 8 | E.R. Squibb & Sons, L.L.C. ($100.47) |
| 2022 | $31.94 | 2 | PFIZER INC. ($20.13) |
| 2021 | $2,091 | 7 | Bayer HealthCare Pharmaceuticals Inc. ($1,760) |
| 2020 | $1,184 | 4 | Medtronic, Inc. ($1,060) |
| 2019 | $92,083 | 88 | Novartis Pharmaceuticals Corporation ($61,978) |
| 2018 | $100,487 | 102 | Novartis Pharmaceuticals Corporation ($78,744) |
| 2017 | $81,794 | 96 | Novartis Pharmaceuticals Corporation ($64,330) |
All Payment Transactions
331 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/09/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/24/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Cardiology | ||||||
| 08/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.44 | General |
| Category: Cardiovascular | ||||||
| 07/25/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: DIABETES | ||||||
| 06/04/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.46 | General |
| 05/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Endocrinology | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/16/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.45 | General |
| 04/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/04/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.52 | General |
| Category: Cardiovascular | ||||||
| 03/07/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Endocrinology | ||||||
| 01/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: Cardiology | ||||||
| 11/08/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 400 | 466 | $92,254 | $33,584 |
| 2022 | 9 | 299 | 486 | $112,060 | $42,887 |
| 2021 | 7 | 260 | 431 | $82,315 | $32,116 |
| 2020 | 8 | 183 | 296 | $65,353 | $18,908 |
Total Patients
1,142
Total Services
1,679
Medicare Billing
$127,494
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 80 | $18,262 | $7,577 | 41.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 33 | 34 | $14,217 | $4,804 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 35 | $8,391 | $3,558 | 42.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 54 | $8,442 | $3,485 | 41.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $8,616 | $3,132 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 34 | $6,154 | $2,602 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,175 | $1,813 | 43.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 26 | 26 | $5,766 | $1,289 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 23 | 25 | $2,950 | $1,164 | 39.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,574 | $1,132 | 44.0% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 12 | 12 | $4,912 | $1,043 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $2,177 | $986.57 | 45.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 24 | 24 | $2,112 | $345.60 | 16.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 24 | 24 | $1,416 | $239.12 | 16.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 11 | 11 | $770.00 | $149.42 | 19.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $600.00 | $147.00 | 24.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 14 | 16 | $544.00 | $93.66 | 17.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 11 | 11 | $176.00 | $25.92 | 14.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 78 | 225 | $51,525 | $19,131 | 37.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 47 | $20,398 | $7,952 | 39.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 60 | 85 | $13,430 | $5,045 | 37.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 39 | 40 | $11,760 | $4,698 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 24 | 30 | $5,430 | $2,306 | 42.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 14 | 14 | $3,052 | $1,192 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $3,047 | $1,138 | 37.4% |
About Dr. Richard Soucier, MD
Dr. Richard Soucier, MD is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255334207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Soucier, MD has received a total of $278,374 in payments from pharmaceutical and medical device companies, with $514.35 received in 2024. These payments were reported across 331 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($236,174).
As a Medicare-enrolled provider, Soucier has provided services to 1,142 Medicare beneficiaries, totaling 1,679 services with total Medicare billing of $127,494. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Other Specialties Cardiovascular Disease
- Location Hartford, CT
- Active Since 05/23/2005
- Last Updated 11/11/2021
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1255334207
Products in Payments
- ENTRESTO (Drug) $201,828
- XARELTO (Drug) $41,883
- CardioMEMS HF System (Device) $18,540
- JARDIANCE (Drug) $8,604
- Kerendia (Drug) $1,760
- Circulatory Support (Device) $402.60
- ELIQUIS (Drug) $157.74
- Confirm Rx (Device) $124.11
- CAMZYOS (Drug) $69.96
- Korlym (Drug) $64.41
- HeartMate 3 Left Ventricular Dev (Device) $57.46
- INJECTAFER (Drug) $54.99
- Repatha (Biological) $53.86
- HeartMate 3 Left Ventricular Assist Device (Device) $49.21
- LEQVIO (Drug) $45.39
- VYNDAQEL (Drug) $41.04
- FARXIGA (Drug) $36.51
- Hillrom - Carnation Ambulatory Monitor (Device) $26.31
- UPTRAVI (Drug) $26.10
- CARDIOMEMS (Device) $24.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.